HCWB vs WHLM Comparison

HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.

Wilhelmina International Inc is engaged in the business of fashion model management. The company provides traditional, full-service fashion model and talent management services, specializing in the representation and management of models, entertainers, artists, athletes and another talent to various clients which include retailers, designers, advertising agencies, print and electronic media and catalog companies. In addition, the company is also engaged in providing fashion modeling and talent product endorsement services to clients such as advertising agencies, branded consumer goods companies, fashion designers, magazine publications, retailers, department stores, product catalogs and Internet sites.